Cited by 697Cardiac Imaging and DiagnosticsAtherosclerosis and Cardiovascular DiseasesCerebrovascular and Carotid Artery Diseases

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With α v β 3 -Integrin–Targeted Nanoparticles

Open access

Winter, Patrick M., Morawski, Anne M., Caruthers, Shelton D., Fuhrhop, Ralph W., Zhang, Huiying, Williams, Todd A., Allen, John S., Lacy, Elizabeth K., Robertson, J. David, Lanza, Gregory M., Wickline, Samuel A.·2003·Circulation

DOI 10.1161/01.cir.0000093185.16083.95

Open this paper in CoChat — free account Open PDF

Abstract

Background— Angiogenesis is a critical feature of plaque development in atherosclerosis and might play a key role in both the initiation and later rupture of plaques that lead to myocardial infarction and stroke. The precursory molecular or cellular events that initiate plaque growth and that ultimately contribute to plaque instability, however, cannot be detected directly with any current diagnostic modality. Methods and Results— Atherosclerosis was induced in New Zealand White rabbits fed 1% cholesterol for ≈80 days. α v β 3 -Integrin–targeted, paramagnetic nanoparticles were injected intravenously and provided specific detection of the neovasculature within 2 hours by routine magnetic resonance imaging (MRI) at a clinically relevant field strength (1.5 T). Increased angiogenesis was detected as a 47±5% enhancement in MRI signal averaged throughout the abdominal aortic wall among rabbits that received α v β 3 -targeted, paramagnetic nanoparticles. Pretreatment of atherosclerotic rabbits with α v β 3 -targeted, nonparamagnetic nanoparticles competitively blocked specific contrast enhancement of the α v β 3 -targeted paramagnetic agent. MRI revealed a pattern of increased α v β 3 -integrin distribution within the atherosclerotic wall that was spatially heterogeneous along both transverse and longitudinal planes of the abdominal aorta. Histology and immunohistochemistry confirmed marked proliferation of angiogenic vessels within the aortic adventitia, coincident with prominent, neointimal proliferation among cholesterol-fed, atherosclerotic rabbits in comparison with sparse incidence of neovasculature in the control animals. Conclusions— This molecular imaging approach might provide a method for defining the burden and evolution of atherosclerosis in susceptible individuals as well as responsiveness of individual patients to antiatherosclerotic therapies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000093185.16083.95

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Sudden Cardiac Death in the United States, 1989 to 1998
Zheng, Z., Croft, J. B., Giles, W. H., & Mensah, G. A. (2001) · Circulation · doi:10.1161/hc4301.098254 · Cited by 1,597
Angiogenesis Inhibitors Endostatin or TNP-470 Reduce Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice
Moulton, K. S., Heller, E., Konerding, M. A., Flynn, E., Palinski, W., & Folkman, J. (1999) · Circulation · doi:10.1161/01.cir.99.13.1726 · Cited by 688
Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits
Ruehm, S. G., Corot, C., VOGT, P. R., Kolb, S., & Debatin, J. F. (2001) · Circulation · doi:10.1161/01.cir.103.3.415 · Cited by 606
Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques
Flacke, S., Fischer, S., Scott, M. J., Fuhrhop, R. J., Allen, J. S., McLean, M., Winter, P., Sicard, G. A., Gaffney, P. J., Wickline, S. A., et al. (2001) · Circulation · doi:10.1161/hc3601.094303 · Cited by 515
Self-citation
Water diffusion compartmentation and anisotropy at high b values in the human brain
Clark, C. A., & Bihan, D. L. (2000) · Magnetic Resonance in Medicine · doi:10.1002/1522-2594(200012)44:6 · Cited by 432
Self-citation
Contrast‐enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization
Yuan, C., Kerwin, W. S., Ferguson, M. S., Polissar, N. L., Zhang, S., Cai, J., & Hatsukami, T. S. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10030 · Cited by 422
A Novel Site-Targeted Ultrasonic Contrast Agent With Broad Biomedical Application
Lanza, G. M., Wallace, K. D., Scott, M. J., Cacheris, W. P., Abendschein, D. R., Christy, D. H., Sharkey, A. M., Miller, J. G., Gaffney, P. J., & Wickline, S. A. (1996) · Circulation · doi:10.1161/01.cir.94.12.3334 · Cited by 406
Self-citation
Quantitative Magnetic Resonance Imaging Analysis of Neovasculature Volume in Carotid Atherosclerotic Plaque
Kerwin, W. S., Hooker, A. C., Spilker, M. E., Vicini, P., Ferguson, M. S., Hatsukami, T. S., & Yuan, C. (2003) · Circulation · doi:10.1161/01.cir.0000048145.52309.31 · Cited by 353
Targeted Antiproliferative Drug Delivery to Vascular Smooth Muscle Cells With a Magnetic Resonance Imaging Nanoparticle Contrast Agent
Lanza, G. M., Yu, X., Winter, P. M., Abendschein, D. R., Karukstis, K. K., Scott, M. J., Chinen, L. K., Fuhrhop, R. W., Scherrer, D. E., & Wickline, S. A. (2002) · Circulation · doi:10.1161/01.cir.0000044020.27990.32 · Cited by 288
Self-citation

Show all 24 references

Research works printed but not linked: 9

10.1161/circ.104.18.2158 · DOI
2002, J Cardiovasc Risk, 9, 237
2002, J Endovasc Ther, 9, 529
1994, Am J Pathol, 145, 883
10.1161/circ.104.11.1280 · DOI
10.1161/circ.94.12.3334 · DOI
10.1161/circ.99.13.1653 · DOI
10.1161/circ.105.4.415 · DOI
10.1161/circ.103.3.415 · DOI

Sorted by citations

Items 301–400 of 697

Oxidation of human plasma fibronectin by inflammatory oxidants perturbs endothelial cell function
Vanichkitrungruang, S., Chuang, C. Y., Hawkins, C. L., Hammer, A., Höefler, G., Malle, E., & Davies, M. J. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.04.003 · Cited by 33
Cardiovascular molecular imaging of apoptosis
Wolters, S. L., Corsten, M. F., Reutelingsperger, C. P. M., Narula, J., & Hofstra, L. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0443-0 · Cited by 33
MR Molecular Imaging of Aortic Angiogenesis
Cai, K., Caruthers, S. D., Huang, W., Williams, T. A., Zhang, H., Wickline, S. A., Lanza, G. M., & Winter, P. M. (2010) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2010.03.012 · Cited by 33
Self-citation
CD44 Regulates Vascular Gene Expression in a Proatherogenic Environment
Zhao, L., Hall, J. A., Levenkova, N., Lee, E. F., Middleton, M. K., Zukas, A. M., Rader, D. J., Rux, J. J., & Puré, E. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000259362.10882.c5 · Cited by 33
Nanomedicine Captures Cardiovascular Disease
Mulder, W. J. M., & Fayad, Z. A. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.165332 · Cited by 34
Contrast enhancement by differently sized paramagnetic MRI contrast agents in mice with two phenotypes of atherosclerotic plaque
van Bochove, G. S., Paulis, L. E. M., Segers, D., Mulder, W. J. M., Krams, R., Nicolay, K., & Strijkers, G. J. (2010) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.402 · Cited by 33
OxLDL-targeted iron oxide nanoparticles for in vivo MRI detection of perivascular carotid collar induced atherosclerotic lesions in ApoE-deficient mice
Wen, S., Liu, D., Liu, Z., Harris, S. S., Yao, Y., Ding, Q., Nie, F., Lu, T., Chen, H., An, Y., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m018895 · Cited by 31
1H Relaxivity of Water in Aqueous Suspensions of Gd3+-Loaded NaY Nanozeolites and AlTUD-1 Mesoporous Material: the Influence of Si/Al Ratio and Pore Size
Norek, M., Neves, I. C., & Peters, J. A. (2007) · Inorganic Chemistry · doi:10.1021/ic700699n · Cited by 32
Quantitative Longitudinal Imaging of Vascular Inflammation and Treatment by Ezetimibe in apoE Mice by FMT Using New Optical Imaging Biomarkers of Cathepsin Activity and αvβ3 Integrin
Lin, S.-A., Patel, M. R., Suresch, D. L., Connolly, B., Bao, B., Groves, K., Rajopadhye, M., Peterson, J. D., Klimas, M. T., Sur, C., et al. (2012) · International Journal of Molecular Imaging · doi:10.1155/2012/189254 · Cited by 32
Detecting the vulnerable plaque in patients
Gonçalves, I., den Ruijter, H. M., Nahrendorf, M., & Pasterkamp, G. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12414 · Cited by 32
Recent strategies to design vascular theranostic nanoparticles
Gupta, M. K., Lee, Y., Boire, T. C., Lee, J.-B., Kim, W. S., & Sung, H. (2017) · Nanotheranostics · doi:10.7150/ntno.18531 · Cited by 32
Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin α4β1
Woodside, D. G., Tanifum, E. A., Ghaghada, K. B., Biediger, R. J., Caivano, A. R., Starosolski, Z. A., Khounlo, S., Bhayana, S., Abbasi, S., Craft, J. W., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21893-x · Cited by 32
Targeted molecular imaging of vascular inflammation in cardiovascular disease using nano- and micro-sized agents
McAteer, M. A., & Choudhury, R. P. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.10.005 · Cited by 31
Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-tesla magnetic resonance scanner
Li, X., Du, X., Huo, T., Liu, X., Zhang, S., & Yuan, F. (2009) · Acta Radiologica · doi:10.1080/02841850902902557 · Cited by 31
The gold standard for noninvasive imaging in coronary heart disease: magnetic resonance imaging
Vick, G. W. (2009) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283315553 · Cited by 31
Molecular MRI of Atherosclerosis
Phinikaridou, A., Andía, M. E., Lacerda, S., Lorrio, S., Makowski, M. R., & Botnar, R. M. (2013) · Molecules · doi:10.3390/molecules181114042 · Cited by 30
Construction of CNA35 Collagen-Targeted Phase-Changeable Nanoagents for Low-Intensity Focused Ultrasound-Triggered Ultrasound Molecular Imaging of Myocardial Fibrosis in Rabbits
Zhou, Q., Zeng, Y., Xiong, Q., Zhong, S., Li, P., Ran, H., Yin, Y., Reutelingsperger, C. P. M., Prinze, F. W., & Ling, Z. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b05999 · Cited by 30
Current advances in the imaging of atherosclerotic vulnerable plaque using nanoparticles
Zhang, M., Xie, Z., Long, H., Ren, K., Hou, L., Wang, Y., Xu, X., Lei, W., Yang, Z., Ahmed, S., et al. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100236 · Cited by 31
Self-citation
Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis
Calcagno, C., Ramachandran, S., Millon, A., Robson, P. M., Mani, V., & Fayad, Z. A. (2012) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-012-9177-x · Cited by 30
Imaging Subclinical Atherosclerosis: Is It Ready for Prime Time? A Review
Fernández‐Friera, L., Ibáñez, B., & Fuster, V. (2014) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-014-9582-4 · Cited by 30
Contrast enhancement in atherosclerosis development in a mouse model: in vivo results at 2 Tesla
Chaabane, L., Pellet, N., Bourdillon, M. C., Desbleds‐Mansard, C., Sulaiman, A., Hadour, G., Thivolet-B�jui, F., Roy, P., Briguet, A., Douek, P., et al. (2004) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-004-0055-7 · Cited by 30
Magnetic resonance imaging and computed tomography in assessment of atherosclerotic plaque
Fayad, Z. A., Sirol, M., Nikolaou, K., Choudhury, R. P., & Fuster, V. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0037-2 · Cited by 30
Applications for site-directed molecular imaging agents coupled with drug delivery potential
Wang, H., & Chen, X. S. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902889751 · Cited by 30
Implant-forming polymeric 19F MRI-tracer with tunable dissolution
Kolouchová, K., Jirák, D., Groborz, O., Sedláček, O., Ziółkowska, N., Vít, M., Sticová, E., Gálisová, A., Švec, P., Trousil, J., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.026 · Cited by 29
Biomarkers of atherosclerosis and the potential of MRI for the diagnosis of vulnerable plaque
Canet‐Soulas, E., & Letourneur, D. (2007) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-007-0078-y · Cited by 29
MR-optical imaging of cardiovascular molecular targets
Nahrendorf, M., Sosnovik, D. E., & Weissleder, R. (2008) · Basic Research in Cardiology · doi:10.1007/s00395-008-0707-2 · Cited by 29
Imaging Dose-dependent Pharmacokinetics of an RGD-Fluorescent Dye Conjugate Targeted to α v β 3 Receptor Expressed in Kaposi's Sarcoma
Kwon, S., Shi, K., Houston, J. P., Wang, W., Wu, Q., Li, C., & Sevick-Muraca, E. M. (2005) · Molecular Imaging · doi:10.1162/15353500200505103 · Cited by 29
Validation of Ultrasound Super-Resolution Imaging of Vasa Vasorum in Rabbit Atherosclerotic Plaques
Chen, Q., Yu, J., Lukashova, L., Latoche, J. D., Zhu, J., Lavery, L., Verdelis, K., Anderson, C. J., & Kim, K. (2020) · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control · doi:10.1109/tuffc.2020.2974747 · Cited by 28
MR cholangiography demonstrates unsuspected rapid biliary clearance of nanoparticles in rodents: Implications for clinical translation
Bulte, J. W. M., Schmieder, A. H., Keupp, J., Caruthers, S. D., Wickline, S. A., & Lanza, G. M. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.05.001 · Cited by 27
Self-citation
Emerging Engineered Magnetic Nanoparticulate Probes for Molecular MRI of Atherosclerosis: How Far Have We Come?
Kanwar, R. K., Chaudhary, R., Tsuzuki, T., & Kanwar, J. R. (2012) · Nanomedicine · doi:10.2217/nnm.12.57 · Cited by 27
Evaluation of receptor‐ligand mechanisms of dual‐targeted particles to an inflamed endothelium
Fromen, C. A., Fish, M. B., Zimmerman, A., Adili, R., Holinstat, M. A., & Eniola‐Adefeso, O. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10008 · Cited by 27
MR and optical approaches to molecular imaging
ten Persigehl, T., Heindel, W. L., & Bremer, C. (2005) · Abdominal Imaging · doi:10.1007/s00261-004-0230-3 · Cited by 25
Quantifying the Evolution of Vascular Barrier Disruption in Advanced Atherosclerosis with Semipermeant Nanoparticle Contrast Agents
Zhang, H., Zhang, L., Myerson, J. W., Bibee, K., Scott, M., Allen, J. S., Sicard, G. A., Lanza, G. M., & Wickline, S. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026385 · Cited by 27
Self-citation
Molecular Imaging in Cardiovascular Magnetic Resonance Imaging
Sosnovik, D. E. (2008) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0b013e318176c57b · Cited by 26
Magnetic Resonance Molecular Imaging Contrast Agents and Their Application in Atherosclerosis
Mulder, W. J. M., Strijkers, G. J., Vucic, E., Cormode, D. P., Nicolay, K., & Fayad, Z. A. (2007) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0b013e31815a0e7f · Cited by 27
Standardization of Models and Methods Used to Assess Nanoparticles in Cardiovascular Applications
Fitzgerald, K. T., Holladay, C. A., McCarthy, C., Power, K. A., Pandit, A., & Gallagher, W. M. (2011) · Small · doi:10.1002/smll.201001347 · Cited by 26
Molecular imaging in cardiovascular disease: Which methods, which diseases?
Lindner, J. R., & Sinusas, A. J. (2013) · Journal of Nuclear Cardiology · doi:10.1007/s12350-013-9785-0 · Cited by 26
Current Techniques for MR Imaging of Atherosclerosis
Balu, N., Wang, J., Dong, L., Baluyot, F., Chen, H., & Yuan, C. (2009) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0b013e3181ea287d · Cited by 26
The Future of Cardiovascular Imaging in the Diagnosis and Management of Heart Failure, Part 1
Marwick, T. H., & Schwaiger, M. (2008) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.108.792408 · Cited by 26
Advances in non-invasive drug delivery for atherosclerotic heart disease
Maranhão, R. C., & Tavares, E. R. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.999663 · Cited by 25
18F-Fluorodeoxyglucose PET Imaging of Coronary Atherosclerosis and Plaque Inflammation
Chen, W., & Dilsizian, V. (2010) · Current Cardiology Reports · doi:10.1007/s11886-010-0095-8 · Cited by 27
Iron oxide core oil-in-water nanoemulsion as tracer for atherosclerosis MPI and MRI imaging
Prévot, G., Kauss, T., Lorenzato, C., Gaubert, A., Larivière, M., Baillet, J., Laroche‐Traineau, J., Jacobin‐Valat, M., Adumeau, L., Mornet, S., et al. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.010 · Cited by 27
Biomimetic MRI Contrast Agent for Imaging of Inflammation in Atherosclerotic Plaque of ApoE−/− Mice
Alsaid, H., Souza, G. D., Bourdillon, M. C., Chaubet, F., Sulaiman, A., Desbleds‐Mansard, C., Chaabane, L., Zahir, C., Lancelot, E., Rousseaux, O., et al. (2009) · Investigative Radiology · doi:10.1097/rli.0b013e31819472ac · Cited by 25
A new macromolecular paramagnetic MR contrast agent binds to activated human platelets
Chaubet, F., Bertholon, I., Serfaty, J., Bazeli, R., Alsaid, H., Jandrot‐Perrus, M., Zahir, C., Even‐Hernandez, P., Bachelet, L., Touat, Z., et al. (2007) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.144 · Cited by 25
Molecular Imaging: A Primer for Interventionalists and Imagers
Wang, D. S., Dake, M. D., Park, J. M., & Kuo, M. (2006) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000235746.86332.df · Cited by 25
Protein MRI Contrast Agents as an Effective Approach for Precision Molecular Imaging
Li, D., Kirberger, M., Qiao, J., Gui, Z., Xue, S., Pu, F., Jiang, J., Xu, Y., Tan, S., Salarian, M., et al. (2024) · Investigative Radiology · doi:10.1097/rli.0000000000001057 · Cited by 25
Utility of Combining PET and MR Imaging of Carotid Plaque
Vesey, A. T., Dweck, M. R., & Fayad, Z. A. (2015) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2015.09.005 · Cited by 24
Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques
Yu, S. S., Ortega, R. A., Reagan, B. W., McPherson, J., Sung, H., & Giorgio, T. D. (2011) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.158 · Cited by 24
National Cancer Institute Alliance for nanotechnology in cancer—Catalyzing research and translation toward novel cancer diagnostics and therapeutics
Hartshorn, C. M., Russell, L. M., & Grodzinski, P. A. (2019) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1570 · Cited by 24
Molecular imaging of plaques in coronary arteries with PET and SPECT.
(2014) · PubMed Central · doi:10.11909/j.issn.1671-5411.2014.03.005 · Cited by 24
Molecular Imaging by Cardiovascular MR
Cyrus, T., Lanza, G. M., & Wickline, S. A. (2007) · Journal of Cardiovascular Magnetic Resonance · doi:10.1080/10976640701693766 · Cited by 24
Self-citation
Vulnerable Plaque Imaging
Chen, J. W., & Wasserman, B. A. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.08.005 · Cited by 24
Extending the Frontiers of Cardiac Magnetic Resonance
Schwitter, J. (2008) · Circulation · doi:10.1161/circulationaha.108.790139 · Cited by 24
Molecular Imaging of Retinal Disease
Capozzi, M. E., Gordon, A. Y., Penn, J. S., & Jayagopal, A. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0279 · Cited by 23
Multimodality Molecular Imaging of Cardiovascular Disease Based on Nanoprobes
Tu, Y., Sun, Y., Fan, Y., Cheng, Z., & Yu, B. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492251 · Cited by 23
Carotid Artery Disease and Stroke: Assessing Risk with Vessel Wall MRI
Kerwin, W. S. (2012) · ISRN Cardiology · doi:10.5402/2012/180710 · Cited by 23
Nuevas técnicas de imagen para la cuantificación de la carga aterosclerótica global
Ibáñez, B., Pinero, A., Orejas, M., & Badimón, J. J. (2007) · Revista Española de Cardiología · doi:10.1157/13100282 · Cited by 23
Surface-modified nanotherapeutics targeting atherosclerosis
Li, W., Gonzalez, K. M., Chung, J., Kim, M., & Lu, J. (2022) · Biomaterials Science · doi:10.1039/d2bm00660j · Cited by 22
Squalene-based nanoparticles for the targeting of atherosclerotic lesions
Brusini, R., Dormont, F., Cailleau, C., Nicolas, V., Peramo, A., Varna, M., & Couvreur, P. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119282 · Cited by 22
Nanotemplate-Engineered Nanoparticles Containing Gadolinium for Magnetic Resonance Imaging of Tumors
Zhu, D., Lü, X., Hardy, P., Leggas, M. L., & Jay, M. (2008) · Investigative Radiology · doi:10.1097/rli.0b013e31815878dd · Cited by 22
Nanotechnology for Sensing, Imaging, and Treating Cancer
Panchapakesan, B., & Wickstrom, E. (2007) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2007.03.002 · Cited by 22
Angiogenesis imaging with vascular-constrained particles: the why and how
Lanza, G. M., Caruthers, S. D., Winter, P. M., Hughes, M. S., Schmieder, A. H., Hu, G., & Wickline, S. A. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1502-5 · Cited by 22
Self-citation
Ultrasonic Analysis of Peptide- and Antibody-Targeted Microbubble Contrast Agents for Molecular Imaging of α v β 3 -Expressing Cells
Dayton, P. A., Pearson, D., Clark, J., Simon, S. I., Schumann, P. A., Zutshi, R., Matsunaga, T. O., & Ferrara, K. W. (2004) · Molecular Imaging · doi:10.1162/15353500200403187 · Cited by 22
Targeted Delivery of Nanoparticles to Blood Vessels for the Treatment of Atherosclerosis
Zong, Q., He, C., Long, B., Huang, Q., Chen, Y., Li, Y., Dang, Y., & Cai, C. (2024) · Biomedicines · doi:10.3390/biomedicines12071504 · Cited by 24
Optical techniques for the molecular imaging of angiogenesis
Eisenblätter, M., Höltke, C., ten Persigehl, T., & Bremer, C. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1514-1 · Cited by 21
Natural Cell Patches: Melanin Nanoparticles for MR Imaging‐Guided Antiatherosclerosis Therapy via Attenuating Macrophage Pyroptosis
Zu, Z., Sheng, J., Qi, J., Yu, M., Zhang, Y., Zheng, T., Xiang, K., Wu, H., Lu, G., & Zhang, L. J. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202212748 · Cited by 21
Nanotechnology and its Relationship to Interventional Radiology. Part II: Drug Delivery, Thermotherapy, and Vascular Intervention
Power, S., Slattery, M. M., & Lee, M. J. (2010) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-010-9967-y · Cited by 21
Perfluorocarbon Nanoparticles: Evolution of a Multimodality and Multifunctional Imaging Agent
Winter, P. M. (2014) · Scientifica · doi:10.1155/2014/746574 · Cited by 21
Self-citation
Quantitative evaluation using the plaque/muscle ratio index panels predicts plaque type and risk of embolism in patients undergoing carotid artery stenting
Takemoto, K., Ueba, T., Takano, K., Abe, H., Hirata, Y., Higashi, T., Inoue, T., Sakata, N., & Yoshimitsu, K. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2012.12.001 · Cited by 21
Nanoparticle contrast agents for CT: their potential and the challenges that lie ahead
Cormode, D. P., & Fayad, Z. A. (2011) · Imaging in Medicine · doi:10.2217/iim.11.17 · Cited by 22
Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation
Stollenwerk, M. M., Pashkunova-Martic, I., Kremser, C., Talasz, H., Thurner, G. C., Aa, A., Wallnöfer, E. A., Helbok, A., Neuhauser, E., Klammsteiner, N., et al. (2010) · Histochemistry and Cell Biology · doi:10.1007/s00418-010-0676-z · Cited by 21
Quantification of Endothelial αvβ3 Expression with High-Frequency Ultrasound and Targeted Microbubbles: In Vitro and In Vivo Studies
Daeichin, V., Kooiman, K., Skachkov, I., Bosch, J. G., Theelen, T. L., Steiger, K., Needles, A., Janssen, B. J., Daemen, M. J. A. P., van der Steen, A. F. W., et al. (2016) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2016.05.005 · Cited by 21
Nanotechnology in the diagnosis and management of heart, lung and blood diseases
Buxton, D. B. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.2.149 · Cited by 20
Novel theranostic approaches to neovascularized atherosclerotic plaques
Boswell-Patterson, C. A., Hétu, M., Pang, S. C.-N., Herr, J. E., Zhou, J., Jain, S., Bambokian, A., & Johri, A. M. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.04.008 · Cited by 21
Imaging biomarkers of cardiovascular disease
Wang, J., Balu, N., Cantón, G., & Yuan, C. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22266 · Cited by 20
CBP knockdown inhibits angiotensin II-induced vascular smooth muscle cells proliferation through downregulating NF-kB transcriptional activity
Yang, J., Jiang, H., Chen, S.-S., Chen, J., Xu, S., Li, W., & Wang, J. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0400-2 · Cited by 20
Delivery of Polymeric Nanoparticles to Target Vascular Diseases
Agyare, E., & Kandimalla, K. K. (2014) · Journal of Biomolecular Research & Therapeutics · doi:10.4172/2167-7956.s1-001 · Cited by 20
Contrast agents for cardiovascular magnetic resonance imaging: an overview
Meloní, M., Barton, S., Xu, L., Kaski, J. C., Song, W., & He, T. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01241a · Cited by 21
Stimuli-responsive and cellular targeted nanoplatforms for multimodal therapy of skin cancer
Padya, B. S., Pandey, A. P., Pisay, M., Koteshwara, K. B., Hariharapura, R. C., Bhat, K. U., Biswas, S., & Mutalik, S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173633 · Cited by 20
Magnetic Resonance Imaging: Utility as a Molecular Imaging Modality
Basilion, J. P., Yeon, S. B., & Botnar, R. M. (2005) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(05)70001-6 · Cited by 20
Modeling and analysis of abnormality detection in biomolecular nano-networks
Ghavami, S., Lahouti, F., & Masoudi‐Nejad, A. (2012) · Nano Communication Networks · doi:10.1016/j.nancom.2012.09.008 · Cited by 19
Molecular Imaging to Identify the Vulnerable Plaque—From Basic Research to Clinical Practice
Kusters, D. H. M., Tegtmeier, J., Schurgers, L. J., & Reutelingsperger, C. P. M. (2012) · Molecular Imaging and Biology · doi:10.1007/s11307-012-0586-7 · Cited by 20
Inflammasomes: a preclinical assessment of targeting in atherosclerosis
Stitham, J., Rodríguez-Vélez, A., Zhang, X., Jeong, S., & Razani, B. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1795831 · Cited by 20
Imaging integrin αvβ3 positive glioma with a novel RGD dimer probe and the impact of antiangiogenic agent (Endostar) on its tumor uptake
Wu, H., Chen, H., Sun, Y., Wan, Y., Wang, F., Jia, B., & Su, X. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.053 · Cited by 19
Cardiovascular therapy through nanotechnology – how far are we still from bedside?
Cicha, I., Garlichs, C. D., & Alexiou, C. (2014) · European Journal of Nanomedicine · doi:10.1515/ejnm-2014-0001 · Cited by 19
The vulnerable plaque: Current concepts and future perspectives on coronary morphology, composition and wall stress imaging
Marques, J. S., & Pinto, F. J. (2014) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2013.07.017 · Cited by 20
Atherosclerosis and Nanotechnology: Diagnostic and Therapeutic Applications
Kratz, J. D., Chaddha, A., Bhattacharjee, S., & Goonewardena, S. N. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6649-2 · Cited by 20
αVβ3 integrin-targeted microSPECT/CT imaging of inflamed atherosclerotic plaques in mice
Vancraeynest, D., Roelants, V., Bouzin, C., Hanin, F., Walrand, S., Bol, V., Bol, A., Pouleur, A., Pasquet, A., Gerber, B. L., et al. (2016) · EJNMMI Research · doi:10.1186/s13550-016-0184-9 · Cited by 19
Preclinical models of atherosclerosis. The future of Hybrid PET/MR technology for the early detection of vulnerable plaque
Cuadrado, I., Saura, M., Castejón, B., Martin, A. M., Herruzo, I., Balatsos, N. A. A., Zamorano, J. L., & Zaragoza, C. (2016) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2016.5 · Cited by 19
Molecular Imaging of Angiogenesis and Vascular Remodeling in Cardiovascular Pathology
Golestani, R., Jung, J., & Sadeghi, M. M. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5060057 · Cited by 19
Magnetic resonance chemical exchange saturation transfer imaging and nanotechnology
Winter, P. M. (2012) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1167 · Cited by 19
Self-citation
Characterization and molecular detection of atherothrombosis by magnetic resonance—potential tools for individual risk assessment and diagnostics
Ala‐Korpela, M., Sipola, P., & Kaski, K. K. (2006) · Annals of Medicine · doi:10.1080/07853890600862418 · Cited by 19
Enhancement and wavelength-shifted emission of Cerenkov luminescence using multifunctional microspheres
Li, J., Dobrucki, L. W., Marjanović, M., Chaney, E. J., Suslick, K. S., & Boppart, S. A. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/2/727 · Cited by 18
Characterization and In Vitro and In Vivo Testing of CB2-Receptor- and NGAL-Targeted Paramagnetic Micelles for Molecular MRI of Vulnerable Atherosclerotic Plaque
Boekhorst, B. C. M. T., Bovens, S. M., Rodrigues-Feo, J., Sanders, H. M. H. F., van de Kolk, C. W. A., de Kroon, A. I. P. M., Cramer, M. J., Doevendans, P. A., ten Hove, M., Pasterkamp, G., et al. (2010) · Molecular Imaging and Biology · doi:10.1007/s11307-010-0323-z · Cited by 18
Advances in molecular imaging of atherosclerosis and myocardial infarction: shedding new light on in vivo cardiovascular biology
Phinikaridou, A., Andía, M. E., Shah, A. M., & Botnar, R. M. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00583.2012 · Cited by 17
Monitoring Brain Repair in Stroke Using Advanced Magnetic Resonance Imaging
Sztriha, L., Tuura, R., Modo, M., Barker, G. J., Williams, S., & Kalra, L. (2012) · Stroke · doi:10.1161/strokeaha.111.649244 · Cited by 17
Perfluorocarbon Nanoparticles for Molecular Imaging and Targeted Therapeutics
Hughes, M. S., Caruthers, S. D., Tran, T., Marsh, J. N., Wallace, K. D., Cyrus, T., Partlow, K. C., Scott, M., Lijowski, M., Neubauer, A. M., et al. (2008) · Proceedings of the IEEE · doi:10.1109/jproc.2007.913500 · Cited by 18
Self-citation
Cardiac magnetic resonance imaging of rapid VCAM-1 up-regulation in myocardial ischemia–reperfusion injury
Grieve, S. M., Lønborg, J., Mazhar, J., Tan, T. C., Ho, E. C., Liu, C., Lay, W. N., Gill, A. J., Kuchel, P. W., Bhindi, R., et al. (2012) · European Biophysics Journal · doi:10.1007/s00249-012-0857-x · Cited by 17
LncRNA DIGIT Accelerates Tube Formation of Vascular Endothelial Cells by Sponging miR-134
Miao, C., Cao, H., Zhang, Y., Guo, X., Wang, Z., & Wang, J. (2018) · International Heart Journal · doi:10.1536/ihj.17-290 · Cited by 17
Retracted
Multi-Scale Imaging of Vascular Pathologies in Cardiovascular Disease
Tiwari, A., Elgrably, B., Saar, G., & Vandoorne, K. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.754369 · Cited by 17

Authors: Winter, P. M., Morawski, A. M., Caruthers, S. D., Fuhrhop, R. W., Zhang, H., Williams, T. A., Allen, J. S., Lacy, E. K., Robertson, J. D., Lanza, G. M., & Wickline, S. A.
Affiliations: Washington University in St. Louis (US)
ORCID: Winter, Patrick M.
Zhang, Huiying
Allen, John S.
Robertson, J. David
Lanza, Gregory M.
Wickline, Samuel A.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2003-11-04
Volume: 108
Issue: 18
Pages: 2270-2274
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.0000093185.16083.95
OpenAlex: W2101681003
Cited by: 696
References: 24
Citations by year: 2026: 3 · 2025: 1 · 2024: 4 · 2023: 10 · 2022: 8 · 2021: 10 · 2020: 17 · 2019: 24 · 2018: 19 · 2017: 17 · 2016: 22 · 2015: 30 · 2014: 44 · 2013: 36 · 2012: 47
FWCI: 31.66
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: American Heart Association
Bristol-Myers Squibb
University of Bristol
National Institutes of Health (5r01hl042950-17)
U.S. Public Health Service (N01-C0-07121)
National Heart, Lung, and Blood Institute (HL 59865, R01HL059865, HL 42950)
Topics: Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cerebrovascular and Carotid Artery Diseases
Keywords: atherosclerosis, angiogenesis, alpha v beta 3 integrin, molecular imaging, paramagnetic nanoparticles, neovasculature, aortic plaque, neointimal proliferation, plaque vulnerability, cholesterol-fed rabbits, MRI contrast agents
MeSH terms: Animals, Aorta, Arteriosclerosis, Cholesterol, Dietary, Contrast Media, Disease Models, Animal, Immunohistochemistry, Magnetic Resonance Imaging, Male, Neovascularization, Pathologic, Particle Size, Rabbits, Sensitivity and Specificity, Integrin alphaVbeta3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With α v β 3 -Integrin–Targeted Nanoparticles

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks